New Report Orders From Repeat Clients

Genip

21/11/2025 07:00

RNS Number : 4234I

GenIP PLC

21 November 2025

 

 

 

 

21 November 2025 

 

GenIP Plc

("GenIP" or the "Company")

 

New Report Orders From Repeat Clients      

 

 

GenIP Plc, an AI-powered innovation intelligence and technology commercialisation company, is pleased to announce it has received a total of 57 new report orders from repeat clients, including two leading U.S. research universities and a returning UK institution. These orders reflect continued demand for GenIP's AI-enabled analytical products and the strengthening of long-term client relationships.

 

The Company has secured 50 new Invention Evaluator report orders from two major U.S universities, both recognised for their substantial innovation output and commercialisation performance: One institution has been repeatedly ranked in the National Academy of Inventors "Top 100 U.S. Universities Granted Utility Patents", demonstrating sustained leadership in translating research into protected intellectual property. The other operates one of the most active university innovation hubs in the United States, publicly tracking thousands of invention disclosures, patent filings, and spinoff ventures annually through its dedicated commercialisation centre.         

 

In addition, a UK university first onboarded in June 2025 has placed a further 7 report orders, demonstrating continued engagement and the recurrent nature of GenIP's services.

 

GenIP believes these repeat orders validate GenIP's value proposition and demonstrate the effectiveness of our AI-powered analytical assessments in supporting technology transfer decisions.

 

Melissa Cruz, CEO of GenIP, commented:

 

"The continued return of leading institutions reinforces the market's need for faster, more reliable decision-support in technology commercialization. We are also seeing a rise in inbound referrals from universities that have reported meaningful improvements in their licensing workflows after adopting our evaluations. This combination of repeat business and organic referrals gives us strong confidence in our growth trajectory as we expand our AI-powered product suite and support more clients globally."      

 

 

For further information regarding GenIP, please visit www.genip.ai, or contact:

 

GenIP Plc
Melissa Cruz, CEO
Via Redchurch Communications
Redchurch Communications (Financial PR)
John Casey
genip@weareredchurch.com

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

Notes to Editors

 

About GenIP

 

GenIP is a next-generation consultancy at the intersection of generative AI and innovation strategy. We empower corporates, venture funds, and research institutions to evaluate, commercialise, and scale breakthrough technologies. By combining proprietary GenAI algorithms with expert human analysis, GenIP delivers decision-grade insights and talent solutions that accelerate innovation outcomes.

 

Service Offerings

 

GenIP operates through two synergistic service lines:

 

Service
Description
Value Proposition
Invention Intelligence Product Suite
AI-powered market intelligence reports assessing the commercial potential of emerging technologies
Enables faster, evidence-based decisions on R&D prioritisation, investment, and IP strategy
Talent and Executive Search Services
Executive search platform using machine learning and NLP to match innovation-driven organisations with commercialisation-ready leadership
De-risks scaling by aligning technical vision with proven executive capability

 

Together, these services form a unified GenAI-enabled platform for innovation triage and execution.

 

Vision & Strategy

 

GenIP aims to become the global leader in generative AI analytics for innovation commercialisation. Our strategy is anchored in three growth pillars:

 

●    Organic Expansion

Scale Invention Evaluator and Recruitment Services through targeted outreach to corporates, VCs, and research institutions, supported by strategic marketing and digital engagement.

●    Service Deepening

Enhance functionality and margin by expanding GenAI capabilities within both service lines-unlocking new use cases and customer segments.

●    Strategic Acquisitions

Pursue bolt-on acquisitions of complementary GenAI services with validated market traction to broaden our offering and accelerate growth.

 

-ENDS-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
NRAPKKBNPBDDCDB